Nuvation Bio Inc. (NUVB) Social Stream
NUVATION BIO INC (NUVB) Price Targets From Analysts
Use the tables below to see what analysts covering NUVATION BIO INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
NUVB's average price target has moved down $11.22 over the prior 38 weeks.
Over the past 46 weeks, NUVB's average upside potential has been 186.8%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NUVB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 120 days, NUVB's average broker recommendation rating worsened by 0.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NUVB as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, NUVATION BIO INC's upside potential (average analyst target price relative to current price) is higher than 1542.31% of them.
- NUVB has a greater average analyst price target than 263.34% of all US stocks.
- NUVATION BIO INC's number of analysts covering the stock is higher than 426.73% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, NUVATION BIO INC's variance in analysts' estimates is lower than -561.77% of them.
Stocks similar to NUVATION BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NKTX, ALXO, and HRMY.
View All Top Stocks by Price Target
Is NUVB a Buy, Hold or Sell? See the POWR Ratings now!